|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.140 USD | +1.67% |
|
+0.88% | +17.18% |
| Market Cap | 2.32B 2.03B 1.88B 1.75B 3.29B 220B 3.31B 22.31B 8.68B 108B 8.72B 8.53B 375B | P/E 2026 * |
-3.82x | P/E 2027 * | 31.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 2.03B 1.88B 1.75B 3.29B 220B 3.31B 22.31B 8.68B 108B 8.72B 8.53B 375B | EV / Sales 2026 * |
3.46x | EV / Sales 2027 * | 3.19x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | +1.67% | ||
| 1 week | +0.88% | ||
| Current month | +2.58% | ||
| 1 month | +10.25% | ||
| 3 months | -5.77% | ||
| 6 months | +20.11% | ||
| Current year | +17.18% |
| 1 week | 8.82 |  | 9.54 |
| 1 month | 8.06 | | 9.54 |
| Current year | 6.23 | | 10.32 |
| 1 year | 6 | | 10.32 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | - | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 65 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/06 | Free | Director | 48,834 | 0.0192% | ||
| 11/06 | Free | Director | 48,834 | 0.0192% | ||
| 11/06 | Free | Director | 48,834 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.67% | +0.88% | -9.50% | +30.57% | 2.28B | |
| +2.87% | +4.57% | +68.97% | +119.22% | 55.19B | |
| +4.00% | +7.51% | +63.67% | +68.77% | 45.75B | |
| -0.77% | -0.67% | -15.34% | -15.95% | 22.98B | |
| +2.93% | +1.17% | -3.97% | +384.78% | 20.76B | |
| -0.26% | -0.58% | +27.55% | -18.57% | 16.26B | |
| +1.16% | +3.86% | +20.23% | -36.42% | 15.42B | |
| -1.08% | -3.11% | +27.20% | +158.30% | 13.05B | |
| +3.30% | +15.02% | +133.24% | +273.89% | 12.45B | |
| -5.63% | -6.39% | +21.79% | - | 12.37B | |
| Average | +0.82% | +3.28% | +33.38% | +107.18% | 21.65B | |
| Weighted average by Cap. | +1.66% | +3.89% | +42.98% | +107.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 671M 586M 542M 506M 950M 63.41B 957M 6.45B 2.51B 31.18B 2.52B 2.46B 108B | 727M 635M 588M 549M 1.03B 68.72B 1.04B 6.98B 2.72B 33.79B 2.73B 2.67B 117B |
| Net income | -674M -589M -545M -508M -954M -63.69B -961M -6.47B -2.52B -31.31B -2.53B -2.48B -109B | 41.89M 36.61M 33.86M 31.6M 59.33M 3.96B 59.77M 402M 157M 1.95B 157M 154M 6.76B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 9.140 $ | +1.67% | 7,404,436 |
| 18/06/26 | 8.990 $ | +0.45% | 8,882,726 |
| 17/06/26 | 8.950 $ | +0.34% | 4,450,756 |
| 16/06/26 | 8.920 $ | -1.55% | 3,575,476 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
